Skip to ContentSkip to Navigation
How to find us dr. A.J. van der Wekken


Clinical Value of EGFR Copy Number Gain Determined by Amplicon-Based Targeted Next Generation Sequencing in Patients with EGFR-Mutated NSCLC

Detecting therapy-guiding RNA aberrations in platelets of non-small cell lung cancer patients

An All-In-One Transcriptome-Based Assay to Identify Therapy-Guiding Genomic Aberrations in Nonsmall Cell Lung Cancer Patients

Clinical utility of circulating tumor DNA as a response and follow-up marker in cancer therapy

Clinical value of EGFR gene amplifications detected using amplicon based targeted next generation sequencing data in lung adenocarcinoma patients

Combined osimertinib, dabrafenib and trametinib treatment for advanced non-small-cell lung cancer patients with an osimertinib-induced BRAF V600E mutation

Molecular imaging biomarkers for immune checkpoint inhibitor therapy

Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations

Nationwide real-world cohort study of first line TKI treatment in epidermal growth factor receptor mutated non-small cell lung cancer

Nationwide Real-world Cohort Study of First-line Tyrosine Kinase Inhibitor Treatment in Epidermal Growth Factor Receptor-mutated Non-small-cell Lung Cancer

Read more


Plasma testing

Longkanker in Perspectief

Oncologie longkanker special

Magazine Longkanker

NOS journaal

RTV noord journaal

Read more